Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Monoclonal antibodies are crucial tools in diagnosing hematological malignancies.
• The common acute lymphoblastic leukemia antigen (CALLA) is a key marker for certain types of leukemia.
• Cross-reactivity of antibodies can lead to diagnostic inaccuracies.

Purpose of the Study:

• To investigate the reactivity of CALLA-specific monoclonal antibodies with normal human cells.
• To determine if CALLA-reactive antibodies can bind to polymorphonuclear neutrophils (PMN).
• To assess the implications of this binding for leukemia diagnostics.

Main Methods:

• Utilized monoclonal antibodies J5, VIL-A1, and BA-3, known to target CALLA.
• Performed immunofluorescence staining on normal human polymorphonuclear neutrophils (PMN).
• Analyzed antigen molecular weight and staining intensity.

Main Results:

• Monoclonal antibodies J5, VIL-A1, and BA-3 specifically stained normal human PMN.
• The antigen on PMN shares similar molecular weight (95,000-110,000 mol wt) with CALLA (95,000-100,000 mol wt).
• PMN staining intensity was comparable to CALLA-positive leukemic cells.

Conclusions:

• The surface membrane antigens on PMN and CALLA-positive cells are likely related or identical.
• The presence of PMN in patient samples may cause false-positive results in diagnosing acute lymphoblastic leukemia.
• Further validation is needed to refine diagnostic protocols using CALLA antibodies.